Home
>
US Stocks
>
Chemomab Therapeutics Ltd - ADR
Chemomab Therapeutics Ltd - ADR
CMMB

Chemomab Therapeutics Ltd - ADR

$9.3229.07%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
8.88
Today Low/High
8.86 / 9.79
52 Week Low/High
$13 / $2.7K
Market Cap
$146.12M

Company Details

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a monoclonal antibody designed to bind and block CCL24 activity. CM-101 has potential to treat multiple severe and life-threatening inflammatory and fibrotic diseases and is currently undergoing clinical development with primary focus for the orphan diseases, Primary Sclerosing Cholangitis (PSC) and Systemic Sclerosis (SSc). Chemomab is advancing in parallel three Phase 2 clinical trials with CM-101 in fibrotic indications and expecting to report data during 2021-2022.
Organisation
Chemomab Therapeutics Ltd - ADR

Discover more

Frequently Asked Questions

What is Chemomab Therapeutics Ltd - ADR share price today

Can Indians buy Chemomab Therapeutics Ltd - ADR shares?

How can I buy Chemomab Therapeutics Ltd - ADR shares from India?

Can Fractional shares of Chemomab Therapeutics Ltd - ADR be purchased?

What are the documents required to start investing in Chemomab Therapeutics Ltd - ADR stocks?

We are a SEBI registered investement advisor